Skip to content

Karl B. Scheidweiler

3 papers in the library · 54 citations · publishing 2009-2013

Papers

Sort Most recent Most cited

Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA) and Its Pharmacodynamic Consequences in the Rat

Drug Metabolism and Disposition October 19, 2013 Marta Concheiro, Michael H. Baumann, Karl B. Scheidweiler et al. 32 citations

3,4-Methylenedioxymethamphetamine (MDMA) is a widely abused illicit drug that can cause severe and even fatal adverse effects. However, interest remains for its possible clinical applications in posttraumatic stress disorder and anxiety treatment. Preclinical studies to determine MDMA's safety are needed. We evaluated MDMA's pharmacokinetics and metabolism in male rats receiving 2.5, 5, and 10...

MDMA and Metabolite Disposition in Expectorated Oral Fluid After Controlled Oral MDMA Administration

Therapeutic Drug Monitoring October 1, 2011 Allan J. Barnes, Karl B. Scheidweiler, Erin A. Kolbrich-Spargo et al. 22 citations

Oral fluid monitoring efficiently detects single, recreational 70-150 mg of MDMA use for 1-2 days. These controlled administration data provide a scientific basis for interpreting MDMA oral fluid test results.

Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat.

Drug metabolism and disposition: the biological fate of chemicals November 2009 Michael H Baumann, Dorota Zolkowska, Insook Kim et al.

Based on animal data, there is speculation that (+ or -)-3,4-methylenedioxymethamphetamine (MDMA) is neurotoxic to humans. Extrapolation of MDMA findings from animals to humans requires assessment of pharmacokinetics in various species, and low-dose administration data from rats are lacking. In this study, we examine MDMA pharmacokinetics in rats given low (2 mg/kg) and high (10 mg/kg) doses of...